JPRN-UMIN000005912
Recruiting
Phase 2
Phase II study of neo-adjuvant chemotherapy with combination therapy of gemcitabine and S-1 in patients with resectable pancreatic cancer - PK-NACGS PhaseII
Conditionsresectable pancreatic cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- resectable pancreatic cancer
- Sponsor
- Tokai university, school of medicine
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)pulmonary fibrosis or interstitional pneumonaitis 2\)prior anti\-cancer therapy(chemotherapy,radiation therapy ,chemoradiation therapy) 3\)active infection 4\)syncronous cancers 5\)severe complication 6\)severe mental disorder 7\)watery diarrhea 8\)pregnancy 9\)iodine allergy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study of neoadjuvant chemotherapy with CPT-11 and S-1 for locally advanced colorectal cancer with lymph node metastases.locally advanced colorectal cancer with lymph node metastasesJPRN-UMIN000001698iigata Colorectal cancer Chemotherapy Study Group (NCCSG)35
Completed
Not Applicable
PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancerHER2 positive resectable primary breast cancerJPRN-UMIN000008465Osaka Breast Cancer Chemo-Endocrine Therapy Study Group30
Recruiting
Phase 2
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancerpancreatic cancerC535836JPRN-jRCT1041230068Ebata Tomoki50
Recruiting
Phase 2
Phase II Study of neoadjuvant chemotherapy with carboplatin,pemetrexed and bevacizumab in patients with non-squemous non-small-cell lung canceron-squamous,non-small-cell lung cancerJPRN-UMIN000006759niversity of Tsukuba, Faculty of Medicine, Department of Thoracic Surgery30
Completed
Phase 2
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 in advanced esophageal cancer patients with normal oral intakeesophageal cancerJPRN-UMIN000017153Second Department of Surgery, Wakayama Medical University40